£34.5M
Georgian led the round with participation from Twilio Ventures and previous investors.
"Previous attempts at contact center automation have been disappointing,"
Amadeus
Venture CapitalAmadeus Capital Partners is an investor backing trailblazers solving hard problems across intelligence, human, and planet technology areas from seed to growth stages.
Recent investments
$15.0M
The seed round was led by Ahren to commercialise research from the Medical Research Council.
"I am pleased that we have attracted significant support and seed funding to establish Constructive Bio and capture this opportunity. By taking inspiration from nature and reimagining what life can become we have the opportunity to build the sustainable industries of the future."
£45.0M
The Series B round was led by New Science Ventures to support international growth and manufacturing expansion.
"Our increasing desire for continually improving electronic device performance paired with the absolute necessity to reduce our power requirements, and hence carbon footprints, demands new technology solutions – next generation materials will be at the heart of this. At Paragraf we are proud to be leading the way, bringing the first 2D material, graphene, into the electronic product supply chain, through our first products, allowing its transformational, game changing properties and benefits to be harnessed."
£31.4M
The Cambridge biotechnology company has raised £31.4m from investors including M&G and Amadeus Capital Partners to advance its desktop protein printer.
"There’s a fundamental productivity problem in biotech today. A biotech scientist needs to know how to make proteins to design drugs. That’s like expecting a computer scientist to know how to build a computer to design software,"
£5.5M
The financing was led by Zetta Venture Partners alongside Amadeus Capital Partners and Speedinvest to fund international growth and product development.
"It will be used—but it will also be abused."
